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Objective: Type D personality is a combination of high negative affectivity (NA) and high social inhibition (SI).
This trait is related to increased mortality and poor health outcomes in patients with cardiovascular diseases,
although it is less well-established if Type D personality also poses an increased risk in healthy populations. A
potential underlying pathway could include the metabolic syndrome and the combination of abdominal
obesity, subnormal levels of triglycerides and HDL-cholesterol, elevated blood pressure, and increased plasma
glucose levels. We investigated if Type D personality shows a cross-sectional and longitudinal association
with metabolic syndrome in a working population.
Methods: Poisson regression and linear regression were used to estimate the association between Type D
personality and its subscales (NA) and (SI) with objectively establishedmetabolic syndromemarkers in cross-
sectional (n=458) and prospective (n=268, 6.3 years follow-up) analyses of data from an occupational
cohort (mean age=35.9 years, SD=11.7; 80% male).
Results: Type D personality was neither associated with the metabolic syndrome nor with any of its
subcomponents.
Conclusion: The present study does not support a role for metabolic syndrome as a mediating mechanism.
More research is needed that examines potential pathways linking Type D personality with cardiovascular
disease outcomes.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Type D, or ‘distressed,’ personality refers to the combined
tendency to experience negative emotions (high negative affectivity)
and to inhibit self-expression in social interactions (high social
inhibition) [1]. In patients with cardiovascular disease (CVD) Type D
personality has been found to strongly predict poor health outcomes,
including mortality [2]. Several mechanisms have been proposed as
possible mediators of the link between Type D and cardiovascular
disease outcomes [3,4]. These mechanisms include behavioral factors,
like inadequate consultation behavior, sedentary lifestyle, and poor
diet [5,6], as well as biological factors such as increased inﬂammatory
activity [7,8] and altered HPA-axis activity [9–11].
In light of the robust risk prediction in CVD patients, it is surprising
that relatively little research has been conducted in other than patient
populations. Type D personality has a high prevalence in communityMedical Psychology, Tilburg
lands. Tel.: +31 13 466 2715;
Mommersteeg).
r OA license.samples (13–38%) [12,13] where it is associated with increased poor
mental and physical health status [12]. It seems warranted, therefore,
to study if Type D personality poses an increased cardiovascular risk in
predominantly healthy populations.
An obvious biological pathway for further research is the
metabolic syndrome. Metabolic syndrome refers to a cluster of
established metabolic risk markers which greatly increase the
likelihood for developing arteriosclerosis, cardiovascular disease,
stroke, and type 2 diabetes [14]. It comprises abdominal obesity,
subnormal levels of triglycerides and HDL-cholesterol, elevated blood
pressure, and increased plasma glucose levels [14–16]. The etiology of
metabolic syndrome is complex, but a combination of its components
can be seen as a pre-morbid condition leading to increased
atherosclerosis, glucose resistance and beta-cell dysfunction, which
renders peoplemore likely to develop cardiovascular disease and type
II diabetes [14].
Investigating a large representative community sample, we
observed that self-reported metabolic syndrome was more prevalent
in persons with a Type D personality than in those without [17].
Moreover, hypertension or using medication for hypertension was
related to a higher reported level of negative affectivity, whereas
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was related to an increased social inhibition score [17]. Although this
data is consistent with the hypothesis of metabolic syndrome as a
possible mediating factor, the use of self-reports poses a signiﬁcant
limitation. Hausteiner and colleagues observed that womenwith Type
D personality were more likely to be hypertensive, which was
clinically measured. Surprisingly, men with Type D personality were
less likely to be diagnosed with clinically measured hypercholester-
olemia. No attempt was made to combine these markers into a single
metabolic syndrome score [13].
In sum, data on Type D personality and metabolic syndrome are,
although supportive, sparse and inconclusive. Importantly, the
ﬁndings are based on cross-sectional studies, precluding any in-
ferences regarding potential directions of causality. Therefore the
present study aimed to investigate the cross-sectional and prospec-
tive association between Type D personality and clinically established
metabolic syndrome.
Method
Participants and procedure
The study population was recruited in a single production site of
an airplane manufacturing company in south-west Germany. Repeat-
ed cross-sectional assessments were carried out in 2000/01, 2002 and
2007. In 2000/01 a stratiﬁed random sample of 647 men and women
was drawn from the total workforce (n=1760) and was invited to
participate in the study. Out of the 647 employees eligible for the
study, 537 (83%) completed questionnaires. All participants were
offered a consecutive medical examination, which 332 agreed to
undergo. In the 2002 survey, a stratiﬁed, representative sample of
1117 employees of the same company was invited. Of these
employees, 816 (73%) agreed to participate by both completing a
questionnaire and undergoing medical assessments. Data from both
surveys were combined into one sample after excluding those with
missing values and removing data from individuals participating into
both surveys (in that case, the data from 2000/01 was used). The
combined samples comprised 1224 individuals. In 2007, a third
survey and medical examinations were carried out among employees
of the same production site. It needs to be kept in mind that the
participants in earlier assessments were not actively followed-up for
participation in 2007. Out of the 1224 participants in 2000/01 or 2002
a total of 667 (54.4%) were participating again in 2007.
During the medical examinations every participant completed a
questionnaire assessing demographic factors (age, gender, profes-
sional education, income, job position), health behavior (smoking,
alcohol use, exercise) and psychological status (Type D personality,
depressive symptoms, anxiety). Trained staff determined height and
weight (body mass index), waist circumference and systolic and
diastolic blood pressure (calculated as the average of two manual
blood readings obtained after a 15-min rest period while sitting).
Blood samples for assay of HDL, triglyceride and glucose were
obtained in the morning. Participants were requested to fast over
night. Samples were processed according to standard laboratory
procedures. All subjects participated voluntarily and gave written
informed consent. Participation time was paid as working time. The
local institutional review board approved the study protocol, which is
described in more detail elsewhere [20].
Metabolic syndrome
Metabolic syndrome was deﬁned as meeting at least three of the
following ﬁve criteria: (1) an increased waist circumference (≥94 cm
for men and ≥80 cm for women), (2) hypertension (systolic ≥130
and/or diastolic ≥85 mmHg, or using medication to treat hyperten-
sion), (3) reduced HDL-cholesterol (b40 mg/dL/1.0 mmol/L in men;b50 mg/dL/1.3 mmol/L in women, or medication use for reduced
HDL-cholesterol), (4) increased triglyceride levels (≥150 mg/dL
(≥1.7 mmol/L), or medication use for elevated triglyceride levels),
and (5) increased glucose levels (≥5.6 mmol/L or ≥100 mg/dL), or
being diagnosed with diabetes [14]. In the present paper the
metabolic syndrome was assessed according to the International
Diabetes Federation (IDF)-criteria, with waist circumference cut-offs
in Europeans [14]. The waist circumference was measured at its
narrowest point between the ribs and iliac crest. Blood samples for
analysis of HDL-cholesterol, triglyceride level, and glucose were
collected in the morning and processed according to standard
laboratory procedures. Blood pressure (systolic and diastolic) was
calculated as the average of two readings after a 15 min rest period.
Questionnaires
Type D personality was measured with the 14 item version DS14
[1], each item using a 5-point Likert-scale (0–4 range). A combination
of a high score (cut-off≥10) on both the negative affectivity and
social inhibition subscales is labeled Type D personality. The
Cronbach's alpha observed in the current study was 0.86 (n=501)
for the NA subscale, and 0.87 (n=504) for the SI subscale. In addition,
as it has been suggested that Type D personality is a dimensional
construct [21], continuous scores for NA, SI and their interaction NA ×
SI were therefore used in the analysis as well. The Hospital Anxiety
and Depression Scale (HADS) is a widely used self-report question-
naire comprising 14 four-point Likert-scale items; 7 for assessing
depression (HADS-D) and 7 for anxiety (HADS-A). The HADS assesses
the severity of symptoms experienced during the previous week [22].
Statistical analyses
The 2000–2002 sample was used to assess the relation between
Type D personality andmetabolic syndrome cross-sectionally. Second,
data from 2000–2002 and 2007 were combined for longitudinal
analyses as baseline and follow-up, that is, the 2000–2002 data set
was restricted to individuals without the metabolic syndrome and
combined with the 2007 data to predict incident cases of the meta-
bolic syndrome according to Type D presence across amean follow-up
of 6.29 years (SD=0.66 year, min=4.38 years, max=6.67 years).
People with reported heart disease were excluded from the analysis
(n=25 in 2000–2002, and n=41 in 2007).
In 2000–2002, metabolic syndrome data was available for 1023
participants out of 1224 employees. Due to restricted sampling of
Type D personality in 2000–2002 complete information was available
in 458 participants, which was used for the cross-sectional analysis.
The prospective analysis was based on n=268. Missing case analysis
was done to compare cases with information on metabolic syndrome
presence, but without information on Type D personality in 2000
(n=565), with the complete cases mentioned afore (n=458).
Metabolic syndrome was deﬁned as meeting at least 3 out of 5
criteria.When someonemet three criteria formetabolic syndrome but
had missing cases for the other values, metabolic syndrome was
assigned. On the other hand, when someone did not meet three
criteria, and had missing cases on the other values, no metabolic
syndrome was assigned. The individual components were dichoto-
mized according to clinical cut-off scores [14], as well as used as
continuous variables in the analyses. Variables with no normal
distribution were transformed (negative reciprocal square root of
BMI, SBP, glucose, and natural logarithm of triglyceride level, HDL and
DBP) and employed in additional analyses. The results of these
additional analyses were not substantially different from the results of
the analyses of untransformed variables and are therefore not shown.
In a multivariate analysis continuous scores on the metabolic
syndrome components were related to the Type D subscales negative
affectivity, social inhibition, and the interaction between those two
Table 1
Baseline demographics stratiﬁed by Type D personality
n Total Type D No Type D Test value p value
Age [years] 456 35.9 (11.7) 36.5 (11.2) 35.7 (11.9) 0.51 .476
Sex [male] 457 79.6% (364) 75.7% (109) 81.5% (255) 2.03 .154
Professional education 438 0.21 .900
Apprentice 62.6% (274) 64.1% (91) 61.8% (183)
Technical college 24.9% (109) 23.9% (34) 25.3% (75)
Academic degree 12.6% (55) 12.0% (17) 12.8% (38)
Marital status 442 0.59 .743
Single 36.7% (162) 38.0% (54) 36.0% (108)
Married 56.6% (250) 54.2% (77) 57.7% (173)
Divorced 6.8% (30) 7.7% (11) 6.3% (19)
Income 415 0.06 .970
b2000€ 44.3% (184) 44.8% (60) 44.1% (124)
2000–3000€ 32.5% (135) 32.8% (44) 32.4% (91)
3000+€ 23.1% (96) 22.4% (30) 23.5% (66)
Job position 449 9.28 .054
Area manager 4.9% (22) 2.8% (4) 5.9% (18)
Process owner 10.7% (48) 14.8% (21) 8.8% (27)
Skilled worker 68.8% (309) 71.1% (101) 67.8% (208)
Worker 6.5% (29) 6.3% (9) 6.5% (20)
Apprentice 9.1% (41) 4.9% (7) 11.1% (34)
Smoking [yes] 447 39.6% (177) 39.9% (57) 39.5% (120) 0.01 .938
Alcohol use [g/day] 437 14.3 (18.3) 15.1 (21.1) 14.0 (17.0) 0.31 .578
Exercise [hours/week] 448 2.43 .487
2 h/w 30.4% (136) 27.1% (39) 31.9% (97)
1–2 h/w 23.0% (103) 21.5% (31) 23.7% (72)
b1 h/w 24.8% (111) 25.7% (37) 24.3% (74)
No exercise 21.9% (98) 25.7% (37) 20.1% (61)
HADS-D Depression 454 4.9 (3.3) 7.1 (3.3) 3.9 (2.8) 103.83a b.001
HADS-D Anxiety 454 6.9 (4.1) 9.0 (3.3) 5.9 (4.1) 74.65a b.001
Note. % and (n) or means and (SD) are reported.
Test value χ2 for categorical variables and F value for continuous scores.
a Asymptotically F distributed (Brown–Forsythe).
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age, sex, professional education (as an indication of social economic
status), smoking, alcohol use, and hours of exercise per week. In an
additional analysis z-transformed scores of HADS depression and HADS
anxietywere added separately in theﬁnal step of theprospectivemodel.
For the 2007 sample, the change in the components of metabolic
syndromewere related to the TypeD subscales in amultivariate analysis.
In analyses with a dichotomized metabolic syndrome variable
prevalence ratios (PRs) and risk ratios (RRs) together with 95%
conﬁdence intervals (95% CIs) were calculated using a Poisson
regression with a log-link function and the empirical (robust) variance
[23]. Analyses were controlled for age and sex, and in a second step
additionally for professional education, smoking, alcohol use, and
exercise. These covariates were a priori selected because they are
established risk factors for cardiovascular disease [16].
Separate cross-sectional and longitudinal models were used to
analyze the association between prevalent and incident metabolic
syndrome with either Type D personality, its dichotomized subscales
(negative affectivity and social inhibition together in one model), andTable 2
Metabolic syndrome and its components stratiﬁed by Type D personality
n Total N
Metabolic Syndrome 458 14.0% (64) 1
Components
Waist circumference [cm] 456 88.7 (12.2)
BMI [kg/m2] 458 25.6 (3.8)
Triglyceride [mg/dL] 24 152.8 (125.0) 1
HDL [mg/dL] 458 53.8 (14.0)
SBP [mmHg] 437 125.3 (15.4) 1
DBP [mmHg] 438 79.6 (9.5)
Glucose [mmol/L] 450 5.3 (0.5)
Note. Data from the 2000 cohort were used. % and (n) or means and (SD) are reported.
Test value χ2 for categorical variables and F value for continuous scores.
BMI=body mass index; HDL=high density lipoprotein; SBP=systolic blood pressure; DBthe continuous scores of both negative affectivity and social
inhibition, and their interaction, adjusted for covariates.
All analyses were performed with either SAS (log-linear re-
gressions) (SAS Institute Inc., Cary, North Carolina, USA), or SPSS
(PASW Statistics 18.0, SPSS Inc., Chicago, IL, USA), and a p value of .05
was considered signiﬁcant.
Results
Descriptives
Group descriptives of the cohort in the year 2000 are displayed in Table 1. People
with Type D personality, compared to non-Type D persons, were not different
concerning age, gender, marital status, net monthly income, smoking, alcohol use, or
exercise. However, individuals with Type D versus none-Type D had lower education
levels. The prevalence of Type D personality in the study population was 32%; 30% in
men, and 38% in women (X2 (1, N=457)=2.0, p=.15).
Missing cases analysis
For the 2000 sample (n=1224) Type D personality data was collected from
approximately 40% (n=509), who had a prevalence of 14.0% for themetabolic syndrome.o Type D Type D Test value p value
4.3% (45) 13.2% (19) 0.11 .745
89.0 (11.9) 87.8 (12.8) 0.95 .331
25.6 (3.8) 25.8 (3.9) 0.45 .504
50.8 (144.0) 157.0 (81.0) 0.01 .911
52.8 (13.0) 55.8 (15.0) 4.42 .036
25.7 (15.5) 124.5 (15.2) 0.59 .445
79.5 (9.6) 79.8 (9.3) 0.09 .771
5.2 (0.5) 5.3 (0.5) 5.14 .024
P=diastolic blood pressure.
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360 P.M.C. Mommersteeg et al. / Journal of Psychosomatic Research 71 (2011) 357–363The groupwithout information on Type D personality was on average 5 years older, more
likely to be male, used more alcohol, had an increased waist circumference and BMI,
reducedHDL-cholesterol and increased systolic anddiastolic bloodpressure, andwere less
likely to smoke. There was a trend for an increased prevalence of metabolic syndrome in
this group (18.1%,X2 (1,n=715)=3.64, p=.056). After adjustment for age andgender,
only waist circumference and HDL-cholesterol remained signiﬁcantly different between
the groups. No differences were observed in blood glucose or triglyceride levels. In
addition, therewasnodifference concerning loss to follow-up inbaseline participantswith
Type D personality as compared to thosewithout Type D personality (OR for participation
in 2007 among baseline participants=1.28; CI 0.88–1.84).
Cross-sectional analyses
No differences were observed in metabolic syndrome prevalence between those
with Type D personality (13.2%) and without Type D personality (14.3%) (Table 2).
Type D personality was not associated with waist circumference, BMI, triglyceride
levels, or systolic and diastolic blood pressure [18,19]. However, Type D's had a slightly
and signiﬁcantly increased HDL-level and an increased glucose level compared to non-
Type D's (Table 2).
In further analyses no associations were found between the continuous scores of
negative affectivity, social inhibition, or their interaction with any of the continuous
metabolic syndrome components, when adjusted for covariates (see Table 3a). Also,
Type D and its subcomponents were unrelated to the prevalence metabolic syndrome
(see Table 4a). Age, but none of the other covariates, was signiﬁcantly related to
metabolic syndrome presence in all models (PR=1.05, 95% CI=1.02–1.08).
Longitudinal analyses
After a mean follow-up of 6.3 years, no signiﬁcant longitudinal associations were
observed between the Type D subscales and changes in waist circumference, BMI, HDL-
cholesterol, triglyceride level, blood pressure or glucose level (Table 3b). There were 52
(19.4%) new cases of metabolic syndrome in 2007, but again neither Type D personality
nor its subscales were predictors of incident metabolic syndrome (Table 4b).
Age (continuous) appeared as a signiﬁcant predictor in multivariable models
(RR=1.05, 95% CI=1.02–1.08, p=.003). Also current smoking (yes vs. no) was
associated with an increased incidence of the metabolic syndrome (RR=1.66, 95%
CI=1.03–2.66, p=.037) and, likewise, the risk of developing the metabolic syndrome
decreased with increasing physical exercise (RR=0.78, 95% CI=0.63–0.96, p=0.02
for an linear trend across the categories “no sports,” “b1 h/week,” “2–3 h/week” and
“N2 h/week).
In an additional analysis HADS depression and HADS anxiety were added
separately in the ﬁnal step of the prospective model. Neither the baseline HADS
depression Z-score (RR=1.13, 95%CI 0.91–1.41, p=.25), nor the HADS anxiety Z-score
(RR=1.18, 95% CI 0.95 1.48, p=.13) was associated with the risk of metabolic
syndrome.
Discussion
The aim of this study was to investigate the cross-sectional and
longitudinal associations between Type D personality and the
metabolic syndrome in a predominantly healthy sample. Neither
Type D personality nor its subcomponents (negative affectivity and
social inhibition) appeared to be related to the metabolic syndrome.
Cross-sectional analyses of metabolic syndrome components showed
that people with a Type D personality had a slightly increased HDL-
level and glucose level. This weak association could not be attributed
to either negative affectivity or social inhibition.
This is the ﬁrst prospective study on Type D personality and
development of metabolic syndrome. Neither Type D personality nor
negative affectivity or social inhibition was associated with incident
metabolic syndrome or metabolic syndrome components. Taken
together these ﬁndings indicate that the metabolic syndrome is
unlikely to be a major pathway linking Type D with cardiovascular
disease outcomes. The mechanism relating Type D personality to a
poorer prognosis of cardiovascular disease may be mediated by other
pathways. Increased inﬂammation has been linked to Type D
personality [7,24,25], which in turn has been related to increased
metabolic syndrome risk [16]. It remains to be seen whether these
inﬂammatory pathways interact with Type D personality in the
development and progression of cardiovascular disease. On the other
hand, Type D personality has been associated with physical inactivity
(e.g. [13], an unhealthy lifestyle [17], an unhealthy diet [6,17], poor
adhere to prescribed treatment [26], and poor self-management skills
[6,27], which all comprise likely behavioral explanatory mechanisms.
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Table 4a
Prevalence ratios (PRs) and 95% conﬁdence intervals (CIs) for metabolic syndrome
prevalence by Type D personality
Age- and-sex adjusted Multivariable1
n PR 95% CI n PR 95% CI
Dichotomized scores
Type D 2 455 0.89 0.54–1.44 418 0.89 0.53–1.49
NA 2 High≥10 453 0.71 0.43–1.16 416 0.60 0.35–1.05
SI 2 High≥10 453 1.01 0.63–1.64 416 1.17 0.69–1.97
Continuous scores
NA Z-score 453 0.87 0.68–1.11 416 0.80 0.60–1.08
SI Z-score 453 0.91 0.72–1.16 416 0.94 0.72–1.23
NA×SI Z-score 453 1.07 0.90–1.27 416 1.07 0.89–1.28
1 Adjusted for age, sex, professional education, smoking, alcohol use, and exercise.
2 With respect to low cut-off reference group and non-Type D's.
Table 4b
Risk ratios (RRs) and 95% conﬁdence intervals (CIs) for metabolic syndrome incidence
by Type D personality
Age- and-sex adjusted Multivariable1
n RR 95% CI n RR 95% CI
Dichotomized scores
Type D 2 218 1.06 0.66–1.76 202 1.18 0.73–1.90
NA 2 High≥10 218 1.16 0.71–1.91 202 1.20 0.71–2.03
SI 2 High≥10 218 0.91 0.56–1.48 202 1.01 0.61–1.66
Continuous scores
NA Z-score 218 1.20 0.92–1.57 202 1.28 0.95–1.72
SI Z-score 218 0.91 0.70–1.20 202 0.98 0.75–1.28
NA x SI Z-score 218 0.92 0.74–1.15 202 0.89 0.73–1.08
1 Multivariable adjusted for age, sex, professional education, smoking, alcohol use,
and exercise.
2 Dichotomized scores, reference group is low score, and non-Type D.
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exercise levels, which is in line with some previous studies [6,28].
However 25% of the Type D participants versus 20% of the non-Type D
participants reported ‘no exercise,’ which is consistent with previous
ﬁndings of a more sedentary lifestyle in people with Type D
personality [13,29]. The Type D and the non-Type D group did not
differ on smoking or alcohol intake, which was observed in previous
studies as well [6,13,17,28,30], though a lower level of alcohol intake
has been reported in people with Type D personality [17], and women
with Type D personality [13]. These lifestyle factors have been
controlled for in an adequate manner, and were unlikely to have
affected the main ﬁndings of the previous and our present study.
There was no information available on consultation behavior,
management skills, or diet. These behavioral pathways deserve
further attention when examining explanatory mechanisms in
healthy people with Type D personality.
The cross-sectional ﬁndings of the present study contrast with
those of a recent study based on a self-reported metabolic syndrome
score [17]. In this study, people with Type D personality were twice as
likely to meet criteria for metabolic syndrome (odds ratio=2.2, 95%
CI=1.2–4.0). This disagreement might be attributed to sample
differences between the two studies; participants in the self-report
study were on average 12 years older, and metabolic syndrome
prevalence increases with age. However, the prevalence of the
metabolic syndrome in the older aged study was lower; 7% in the
Dutch self-report study versus 14% in the present study. The low
prevalence is a likely result from self-report, as respondents are
frequently unaware of having hypertension, dyslipidemia and elevat-
ed glucose levels, until clinically established, as was discussed before
[18,19]. This suggests that people with Type D personality tend to
over-report their health problems. Clinical deﬁnitions of themetabolic
syndrome, as used in the present study, are less likely than self-
reported data to be affected by non-differential misclassiﬁcation. Still,
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consistently been related to and increased mortality, which contra-
dicts the hypothesis that personality and health outcomes are simply
linked due to issues related to self-reported data, or an hypothesized
increased likeliness for physician visits.
When compared to the previous Dutch study on Type D and
metabolic syndrome, the participants in the present German cohort
were more often male, had lower educational levels, were less likely
to have a partner, more likely to smoke and less likely to exercise
(more ‘no exercise’), which may add to the increased metabolic
prevalence in the present sample. Still, the prevalence of metabolic
syndrome in the present sample was twice as low (14%) compared to
a population-based cohort of similar age, which reported a prevalence
of the metabolic syndrome in of 33% in men and 25% in women [31].
This may be due to differences in health, which is likely to be better in
our occupational cohort (“healthy worker effect”). Possibly, in such
generally healthy people as in our sample, Type D personality may not
affect the development of the metabolic syndrome yet. Two other
studies have investigated clinically observed cardiac risk factors in
relation to Type D personality in community samples, with different
ﬁndings on components of metabolic syndrome [13,25]. In the study
of Hausteiner, Type D-related sex differences were found for
hypertension and hypercholesterolemia, whereas in the study of
Einvik increased triglyceride and BMI levels were observed for people
with Type D personality [13,25]. These studies did not aggregate the
risk factors into metabolic syndrome prevalence; moreover, no
information was available on the relation between the subscales of
Type D with the cardiac risk factors. Most importantly, these earlier
studies relied on cross-sectional data.
Our ﬁndings are in line with other studies on cardiac risk factors in
healthy samples. Nyklicek and colleagues examined a group of 86
(53% women, aged 27–60) people with work-related but non-cardiac
health problems. In their study Type D personality was not associated
with blood pressure, BMI or activity level [28]. Two other studies, in
healthy young adults, did not observe an association between Type D
personality, or its dimensions NA and SI, with heart rate or blood
pressure either [32,33]. In addition there was no meaningful
association of depression or anxiety on metabolic syndrome risk,
which further conﬁrms the absence of a meaningful association.
The constructs of negative affectivity and social inhibition show
overlap with neuroticism and extraversion, respectively [1,34,35].
Recently, three studies on neuroticism and extraversion, and
metabolic syndrome were published [36–38]. Neuroticism, but not
extraversion, was related to an increased prevalence of metabolic
syndrome [36,38]. However, no signiﬁcant associations were ob-
served between neuroticism and the components of metabolic
syndrome, and the odds ratios for predicting metabolic syndrome
and its components were small [38]. Overall ﬁndings are not
consistent, and there is need for large population-based studies
relating personality to clinically observed metabolic syndrome
prevalence and incidence.
A limitation of the present study could have been the limited
sample size. Assuming a similar outcome compared to the self-report
study, with an odds ratio of 2 for detecting an increased prevalence of
metabolic syndrome, we performed a post-hoc power analysis (J.
Hintze, PASS, 2008, Kaysville, Utah). With a sample size of 455, of
which 30% are in the Type D group, and a 14% prevalence of metabolic
syndrome in the non-Type D group, achieves 76% power at a .05
signiﬁcance level to detect a difference in metabolic syndrome
presence. Thus the present study was not underpowered if indeed a
meaningful association was present.
The sample size in the present study was further limited due to
missing cases. Missing case analysis showed increased waist circum-
ference, decreased HDL-cholesterol, but only a trend for increased
metabolic syndrome presence in the group without information on
Type D personality. Thus the studied sample is somewhat biasedtowards having a decreased risk for metabolic syndrome, which could
have reduced the chance of ﬁnding a difference.
A limitation of the longitudinal analysis is that there is no
information on the follow-up response rate. We cannot rule out
selection bias at follow-up, that is, healthy individuals may have been
more likely to participate. In addition, our data are not well
generalizable to women, as the sample consisted of mostly men.
The strengths of the present study include the longitudinal
analysis, and the adjustments made for all relevant cardiac risk
factors, such as age, sex, education, smoking, alcohol use, and activity
level. Signiﬁcant relations of these risk factors with both metabolic
syndrome prevalence and metabolic syndrome development were
observed. Metabolic syndrome was measured by anthropometric
measure and from blood samples, which adds to the signiﬁcance of
these ﬁndings over self-report measures. Smoking and reduced
physical activity longitudinally predicted metabolic syndrome. Re-
duced physical activity, a less healthy diet, more smoking and
drinking have all been related to Type D personality [6,13,17,25],
but these life style factors did not affect absence of a relation between
Type D personality and metabolic syndrome prevalence or incidence
in our study.
In conclusion, Type D personality was not related to metabolic
syndrome presence or development, which does not support an
overall causal pathway in the development of cardiovascular disease.
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